Detailed price information for Sellas Life Sciences Group Inc (SLS-Q) from The Globe and Mail including charting and trades.
Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor metabolize fructose to suppress immune responses and promote tumor growth, reports a study published on ...
Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader antibody ...
Earlier-line bispecific therapy leverages lower disease refractoriness to drive deeper, more durable responses than typically ...
Sophia Wilson’s family feared they would need to travel to the US for treatment after raising £600,000 – but the Aberdeenshire schoolgirl was instead given the specialist drug at Royal Aberdeen Childr ...
Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has received Investigational New Drug (IND) ...
Research identifies ribosome biogenesis factor MYBBP1A as a driver of acute myeloid leukaemia growth, highlighting a ...
The vagus nerve is a direct link between the gut and brain. Scientists have now used a mouse model to show that changes in ...
As it is, Ren is one of the newest members at the Renaissance School of Medicine at Stony Brook University. An Assistant Professor in the division of Hematology/ Oncology, Ren joined the downstate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results